AccuSift provides high-performance naproxen competitive assay pairings, characterized by exceptional batch‑to‑batch consistency and optimized for IVD kit development (Lateral Flow, Chemiluminescence, ELISA, POCT). These pairings offer high affinity and specificity, facilitating rapid detection.Naproxen exerts anti‑inflammatory, antipyretic, and analgesic effects by inhibiting cyclooxygenase and blocking prostaglandin synthesis, with a relatively weak inhibitory effect on platelet function. Clinically, it is used to treat rheumatoid arthritis, osteoarthritis, gout, and dysmenorrhea. It is particularly suitable for patients intolerant to aspirin, indomethacin, or similar drugs due to anemia, gastrointestinal disorders, or other reasons. For relieving uterine spastic pain, it takes effect within 20 minutes and provides stronger analgesia than an equivalent dose of ibuprofen. Common adverse effects include gastrointestinal symptoms such as nausea and vomiting, as well as nervous system reactions like headache and dizziness. Long‑term use requires monitoring of liver and kidney function. The drug has been illegally added to counterfeit medicines, and judicial practice clearly identifies the illicit addition of naproxen as a component of counterfeit drugs. Naproxen is included in the national medical insurance catalog and should be used under medical supervision.Performance Characteristics:
Sensitivity: ELISA IC50: 5 ppb
Source: Mouse Monoclonal Antibody
Recommended Pairing: (Coating) / (Labeling)
Storage: Long‑term storage at ≤ –20°C; short‑term storage at 2–8°C. Shipped on ice packs.
WeChat
